• L-Alanyl-L-Glutamine
• CAS No: 39537-23-0

• Alpha keto Valin calcium
• CAS No: 51828-94-5

• Alpha keto Lucine calcium
• CAS No: 51828-95-6

• Alpha keto Isolucine calcium
• CAS No: 51828-96-7

• Alpha keto Methionin calcium
• CAS No: 4857-44-7

• 3-Fluoro-4-morpholino aniline
• CAS No: 93246-53-8
• End Use: Linezolide

• 7-Hydroxy-3,4-dihydro-2(1H)-quinolinone
• CAS No: 22246-18-0
• End Use: Aripiprazole

• 4,6-dichloro-2-(propylthio)pyrimidin-5-amine
• CAS No: 145783-15-9
• End Use: Ticagelor

• 4-Methylbenzyl thiocyanate
• CAS No: 18991-39-4
• End Use: Etoricoxib

• 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone
• CAS No: 221615-75-4
• End Use: Etoricoxib

• N-Formyl Piperidine
• CAS No: 2591-86-8
• End Use: Etoricoxib/ Dertivative of Piperidine

• 3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone
• CAS No: 129722-34-5
• End Use: Aripiprazole

• 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one
• CAS No: 120004-79-7
• End Use: Aripiprazole

• 4-phenylmorpholin-3-one
• CAS No: 29518-11-4
• End Use: Rivaroxaban

• 4(4-nitro phenyl)morpholin-3-one
• CAS No: 446292-04-2
• End Use: Rivaroxaban

• 4(4-Amino phenyl)morpholin-3-one
• CAS No: 438056-69-0
• End Use: Rivaroxaban

• 5-chlorothiophene-2-carboxylic acid
• CAS No: 24065-33-6
• End Use: Rivaroxaban/ THiophene Derivative

• 4(2-flouro-4-nitrophenyl)morpholine
• CAS No: 2689-39-6
• End Use: Linezolide

• (R)-Boc-3-amino-4-(2,4,5-trifluorophenyl) butanoic acid
• CAS No: 486460-00-8
• End Use: Sitagliptin

• 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
• CAS No: 762240-92-6
• End Use: Sitagliptin

• 4,6-Dichloro-5-nitro-2-propylthiopyrimidine
• CAS No: 145783-14-8
• End Use: Ticagrelor

• (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride
• CAS No: 1156491-10-9
• End Use: Ticagrelor

• (S)-(+)-3-Hydroxytetrahydrofuran
• CAS No: 86087-23-2
• End Use: Empagliflozin

• 4-(5-Bromo-2-chlorobenzyl)phenol
• CAS No: 864070-18-8
• End Use: Empagliflozin

• 3-Methyl-6-nitro-1H-indazole
• CAS No: 6494-19-5
• End Use: Pazopanib

• 2-Methyl-5-nitrobenzenesulfonamide
• CAS No: 6269-91-6
• End Use: Pazopanib

• 7-Chloro-1,2,3,4-tetrahydro-benzo[b]azepine-5-one
• CAS No: 160129-45-3
• End Use: Tolvaptan

• 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobezoyl)-5H-1-benzazepin-5-one
• CAS No: 137982-91-3
• End Use: Tolvaptan

• (2R,3R,4R,5R)-2-(4-amino-5-flouro-2-oxopyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diacetate
• CAS No: 161599-46-8
• End Use: Capacitabin

• L-2-Aminobutanamid Hydrochloride
• CAS No: 7682-20-4
• End Use: Levetiracetam

• (S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione
• CAS No: 161596-47-0
• End Use: Rivaroxaban

• (S)-2-((2-oxo-3-(4-(3-oxoMorpholino)phenyl) oxazolidin-5-yl)Methyl)isoindoline-1,3-dione
• CAS No: 446292-08-6
• End Use: Rivaroxaban

• (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl
• CAS No: 898543-06-1
• End Use: Rivaroxaban

• (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl] amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid
• CAS No: 361442-00-4
• End Use: Saxagliptin

• (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride
• CAS No: 709031-39-0
• End Use: Saxagliptin

• (R)-9-(2-Phosphonomethoxypropyl)Adenine
• CAS No: 147127-20-6
• End Use: Tenofovir Alfanamide

• 2-(4-fluorophenyl)thiophen
• CAS No: 58861-48-6
• End Use: Canagliflozin

• (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one
• CAS No: 32384-65-9
• End Use: Canagliflozin

• 2-(5-bromo-2-methyl-benzyl-(5-fluorophenyl) thiophene
• CAS No: 1030825-20-7
• End Use: Canagliflozin

• (S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-Methylmethanamine
• CAS No: 866783-12-2
• End Use: Etoricoxib

• 3-(3-Iodopropyl)-7,8-diMethoxy-1,3-dihydro-2H-3-benzazepin-2-one
• CAS No: 148870-57-9
• End Use: Ivabradine Hydrochloride

• (S)-3-[3-[[[(7S)-3,4-DiMethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]Methyl]MethylaMino]propyl]-1,3-dihydro-7,8-diMethoxy-H-3-benzazepin-2-one
• CAS No: 1086026-31-4
• End Use: Ivabradine Hydrochloride

• tert-butyl 4-(6-amino-3-pyridyl)piperazine-1-carboxylate
• CAS No: 571188-59-5
• End Use: Palbociclib

• 6-bromo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyrimidin-7(8H)-on
• CAS No: 1016636-76-2
• End Use: Palbociclib

• tert-butyl 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylate
• CAS No: 571188-82-4
• End Use: Palbociclib

• (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol
• CAS No: 714269-57-5
• End Use: Dapagliflozin Propanedil Monohydrate

• 5-bromo-2-chloro-4’-ethoxydiphenylmethane
• CAS No: 461432-23-5
• End Use: Dapagliflozin Propanedil Monohydrate

• (2R,3S,4R,5S,6S)-6-(4-chloro-3-(4-ethoxybenzyl) phenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate
• CAS No: 461432-25-7
• End Use: Dapagliflozin Propanedil Monohydrate

• (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl] phenoxy]tetrahydro-furantetraacetate
• CAS No: 915095-89-5
• End Use: Dapagliflozin Propanedil Monohydrate

• (1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] methyl]phenyl]-D-Glucitol
• CAS No: 915095-99-7
• End Use: Empagliflozin

• Ethyl chloro[(4-methoxyphenyl) hydrazono]acetate
• CAS No: 27143-07-3
• End Use: Apixaban

• 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone
• CAS No: 545445-44-1
• End Use: Apixaban

• BENZENEAZOMALONONITRILE
• CAS No: 6017-21-6
• End Use: Riociguat

• 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
• CAS No: 256499-19-1
• End Use: Riociguat

• 5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic Acid
• CAS No: 956317-36-5
• End Use: Suvorexant

• 5-Chloro-2-((R)-5-Methyl-[1,4]diazepan-1-yl)benzooxazole hydrochloride
• CAS No: 1266664-66-7
• End Use: Suvorexant

• 4,6-Dichloro-5-(4-bromophenyl)pyrimidine
• CAS No: 146533-41-7
• End Use: Macitentan

• N-Propyl-sulfaMide potassium salt
• CAS No: 1393813-41-6
• End Use: Macitentan

• 7-HYDROXYQUINOLINE-2(1H)-ONE
• CAS No: 70500-72-0
• End Use: Brexpiprazole

• 1-benzo[b]thien-4-yl-, hydrochloride;1-Benzo[b]thien-4-yl-piperazine hydrochloride
• CAS No: 913614-18-3
• End Use: Brexpiprazole

• (3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride
• CAS No: 1062580-52-2
• End Use: Tofacitinib

• (S)-(+)-3-CHLORO-1,2-PROPANEDIOL
• CAS No: 60827-45-4
• End Use: Linezolide

• 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate
• CAS No: 160969-03-9
• End Use: Tofacitinib

• Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
• CAS No: 160844-75-7
• End Use: Silodosin

• 2-(chloromethyl)-4-methylquinazoline
• CAS No: 109113-72-6
• End Use: Linagliptin

• 8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione
• CAS No: 666816-98-4
• End Use: Linagliptin

• (R)-3-(Boc-Amino)piperidine
• CAS No: 309956-78-3
• End Use: Linagliptin

• (S)-PYRROLIDINE-2-CARBOXYLIC ACID AMIDE
• CAS No: 7531-52-4
• End Use: Vildagliptin

• 3-Amino-1-hydroxyadamantane
• CAS No: 702-82-9
• End Use: Vildagliptin

• 123
• CAS No: 58861
• End Use: Linezolide